Conestoga Discovery Investors holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Conestoga Discovery Fund Investors Class CMCMX
- NAV / 1-Day Return 10.30 / −0.19 %
- Total Assets 5.6M
-
Adj. Expense Ratio
1.500%
- Expense Ratio 1.500%
- Distribution Fee Level High
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 31%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis CMCMX
Will CMCMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Mama's Creations Inc Common Stock | 5.73 | 315,337 | Consumer Defensive |
Vericel Corp | 5.39 | 296,626 | Healthcare |
Twist Bioscience Corp | 5.16 | 283,805 | Healthcare |
BioLife Solutions Inc | 4.86 | 267,100 | Healthcare |
Digi International Inc | 4.84 | 266,330 | Technology |
Palomar Holdings Inc | 4.61 | 253,666 | Financial Services |
Transcat Inc | 4.26 | 234,341 | Industrials |
CryoPort Inc | 4.05 | 222,713 | Industrials |
Universal Technical Institute Inc | 3.66 | 201,464 | Consumer Defensive |
Electrovaya Inc | 3.62 | 199,171 | Industrials |